Goodman Tony 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Jun 2, 2025
Insider Transaction Report
Form 4
Goodman Tony
DirectorChief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-29+94,000→ 94,000 totalExercise: $0.69Exp: 2035-05-28→ Common Stock (94,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025.